Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.

Pharmacogenetics and genomics - 1 Jan 2015

Kim In-Wha, Han Nayoung, Kim Myeong Gyu, Kim Therasa, Oh Jung Mi

Abstract excerpt

OBJECTIVE: Individual differences in drug efficacy and toxicity remain an important clinical concern. We investigated copy number variation (CNV) frequencies for pharmacogenes using The Cancer Genome Atlas dataset. MATERIALS AND METHODS: One hundred and fifty-two pharmacogenes were selected from liver hepatocellular carcinoma, lung squamous cell carcinoma (LUSC), acute myeloid leukemia, and lymphoid neoplasm...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Pharmacological
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ Cells

Share to Inactivation, Metabolic

Share to Leukemia

Share to Liver Neoplasms

Share to Lymphoma

Share to Pharmacogenetics

Source

Identifiers

PMID: 25379720
DOI: 10.1097/FPC.0000000000000097

Genes

GSTM1
ABCB1
ABL2
FHIT
GSTP1
GSTT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.PMID 25379720Read ↗

Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics.Semantic proximity Read ↗

Pharmacogenomics in Solid Tumors: A Comprehensive Review of Genetic Variability and Its Clinical ImplicationsSemantic proximity Read ↗

Loss of CYP2D6 sensitizes hepatocellular carcinomas and neuroblastomas to talazoparibSemantic proximity Read ↗

Sulfotransferase gene copy number variation: pharmacogenetics and function.Semantic proximity Read ↗

Single nucleotide and copy number variants of cancer driver genes inform drug response in multiple cancers.Semantic proximity Read ↗

Copy number polymorphisms and anticancer pharmacogenomics.Semantic proximity Read ↗

Pharmacogenetics: technologies to detect copy number variations.Semantic proximity Read ↗

Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients.Semantic proximity Read ↗

Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity.Semantic proximity Read ↗

Genome-wide identification of structural variants in genes encoding drug targets: possible implications for individualized drug therapy.Semantic proximity Read ↗

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.Semantic proximity Read ↗

Whole exome sequencing detects variants of genes that mediate response to anticancer drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.